Literature DB >> 15025253

Minimal hepatic encephalopathy: diagnosis by neuropsychological and neurophysiologic methods.

Parampreet S Kharbanda1, Vivek A Saraswat, Radha K Dhiman.   

Abstract

Minimal hepatic encephalopathy (mHE) consists of cognitive deficits found on neuropsychological and/or neurophysiologic methods in patients with liver disease, present most commonly in cirrhosis. Patients suffering from mHE may have psychomotor slowing and cognitive deficits affecting their ability to perform many activities of daily life, especially driving and other activities requiring subtle cognitive abilities. It has been now been shown that patients with mHE improve after treatment with agents like lactulose and other therapeutic interventions. Neuropsychological and neurophysiologic tests have been widely used and have shown the greatest promise for the detection of mHE. Commonly used psychometric tests include trailmaking tests (number and figure connection tests) and Wechsler Adult Intelligence Scale (WAIS) for verbal and performance skills. Among the various neuropsychological or psychometric tests, trailmaking tests and block design and digit symbol tests from WAIS-performance battery appear to be adequate for diagnosis of mHE. Standardized tests including NCT A and B, line tracing, serial dotting test and digits-symbol test (PSE syndrome test) validated in German patients need validation in other populations. Both exogenous evoked potentials and endogenous event-related potentials have been used extensively in diagnosing mHE. However, the event-related P300 wave is the most consistent wave and can be considered the electrophysiological counterpart of the psychometric tests as both involve active use of the cognitive faculties. Other new tests like the critical flicker frequency have shown some promise but further studies are required to substantiate initial results. In conclusion, a combination of at least two psychometric (trailmaking tests [NCT or FCT], block design and digit symbol test) and neurophysiological tests (P300 auditory evoked potential or electroencephalography with mean dominant frequency) appears to be optimal in detecting mHE.

Entities:  

Mesh:

Year:  2003        PMID: 15025253

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  14 in total

1.  Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Amany Ezzat; Ahmed Megahed; Tarek Barakat
Journal:  Neuroradiology       Date:  2014-07-25       Impact factor: 2.804

2.  Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.

Authors:  Jatinderpal Singh; Barjesh Chander Sharma; Vinod Puri; Sanjeev Sachdeva; Siddharth Srivastava
Journal:  Metab Brain Dis       Date:  2017-01-09       Impact factor: 3.584

3.  Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: a clinical rating scale.

Authors:  Sergei Mechtcheriakov; Ivo-W Graziadei; André Kugener; Julia Wiedemann; Chantal Galbavy; Hartmann Hinterhuber; Josef Marksteiner; Wolfgang Vogel
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

4.  Diagnostic value of fine motor deficits in patients with low-grade hepatic encephalopathy.

Authors:  Sergei Mechtcheriakov; Ivo W Graziadei; Maria Rettenbacher; Ingrid Schuster; Hartmann Hinterhuber; Wolfgang Vogel; Josef Marksteiner
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

5.  Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.

Authors:  Lin Jia; Mei-Hua Zhang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

6.  Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection.

Authors:  Vincenzo Citro; Graziella Milan; Francesca Saveria Tripodi; Antonio Gennari; Paolo Sorrentino; Giovanni Gallotta; Alfredo Postiglione; Giovanni Tarantino
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

7.  Driving Performance Among Patients with Cirrhosis Who Drove to Their Outpatient Hepatology Clinic Appointments.

Authors:  Paul J Thuluvath; Anantha Nuthalapati; Jennifer Price; Anurag Maheshwari
Journal:  J Clin Exp Hepatol       Date:  2015-10-03

8.  Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.

Authors:  Mariano Malaguarnera; Maria Pia Gargante; Erika Cristaldi; Marco Vacante; Corrado Risino; Lisa Cammalleri; Giovanni Pennisi; Liborio Rampello
Journal:  Dig Dis Sci       Date:  2008-03-21       Impact factor: 3.199

Review 9.  Is oral L-acyl-carnitine an effective therapy for hepatic encephalopathy? Review of the literature.

Authors:  Nathan J Shores; Emmet B Keeffe
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

10.  Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China.

Authors:  Ji-Yao Wang; Ning-Ping Zhang; Bao-Rong Chi; Yu-Qing Mi; Li-Na Meng; Ying-Di Liu; Jiang-Bin Wang; Hai-Xing Jiang; Jin-Hui Yang; Yun Xu; Xiao Li; Jian-Ming Xu; Guo Zhang; Xin-Min Zhou; Yu-Zheng Zhuge; De-An Tian; Jin Ye; Yu-Lan Liu
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.